This website is intended for healthcare professionals only

Trending Topic

Comprehensive Anatomical Render Of Breast Cancer In A Human Female
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Circulating tumor DNA (ctDNA) has emerged as an innovative and minimally invasive tool in precision oncology. With a short half-life of 30–120 min, ctDNA provides real-time insight into tumor dynamics.1 In early-stage breast cancer, there is growing evidence supporting its potential for minimal residual disease (MRD) detection and recurrence monitoring. In metastatic breast cancer (MBC), ctDNA […]

Call for Submissions

Shaji K Kumar
< 1 min
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Nov 20th 2017 Oncology & Hematology Review, 2017;13(2):75 DOI: https://doi.org/10.17925/OHR.2017.13.02.75
Select a Section…
1

Article

Dear Colleagues

Oncology & Hematology Review (US) is now accepting submissions to the Spring and Fall 2018 editions.
Oncology & Hematology Review (US) aims to provide practicing oncologists and hematologists with concise and timely articles that provide practical advice relevant to clinical practice.

Authors are invited to submit original research, review articles, case reports, and editorials across all areas of oncology and hematology for consideration. The journal is particularly interested in the submission of real-world studies and topical review articles that provide a concise overview of the latest clinical trial data and developments in the field for busy physicians. Authors can submit their manuscript directly through the Editorial Manager site (details below) and presubmission enquiries can be made to the journal’s editor (nicola.cartridge@touchmedicalmedia.com). Accepted articles are published open access, both in print and online, and authors are actively encouraged to submit accompanying multimedia content alongside their article.

We look forward to working with you.

Shaji K Kumar and the Oncology & Hematology Review (US) team

2

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Close Popup